Search
Close this search box.
Search
Close this search box.

Past Seminars

Blumberg Institue Sponsored Past Seminars

Date

Speaker

Topic

Video Link

(If Available)

September 19, 2024

Mark Yorek, PhD
Professor of Medicine, University of Iowa & Associate Chief of Staff Iowa City VA Health Care System

From Bench to Bedside: Omega-3 Polyunsaturated Fatty Acids as a Potential Treatment for Diabetic Peripheral Neuropathy

September 18, 2024

Rui Liu, PhD
Research Assistant Professor, University of Notre Dame

Short Stories in the Medicinal Chemistry

August 15, 2024

Dr. Albert Jeltsch, PhD
Prof. of Biochemistry, University of Stuttgart, German

Analysis of the specificities of DNA and protein methyltransferases leading to novel insights into epigenetic processes

August 7, 2024

Dr. Llorente Bonoga, PhD
Senior Director, GRACS CMC

Enabling First in Human Studies: Regulatory Requirements, Regulatory Documentation and CMC Risks and Mitigations Part 2:
“Regulatory CMC Considerations for Clinical Studies”

July 25, 2024

Dr. Brett Tounge, PhD
Co-Founder and Managing Partner, Chairman at Mebias Discovery

The discovery and development of non-addictive analgesics utilizing Mebias’ novel drug discovery platform

June 13, 2024

Maarouf Hoteit, MD, AGAF. 
Associate Professor of Clinical Medicine, University of Pennsylvania

Early Detection of Hepatocellular Carcinoma

May 30, 2024

Dr, Manisha Srivastava, PhD. 
Associate Director, GRACS CMC

Enabling First in Human Studies: Regulatory Requirements, Regulatory Documentation and CMC Risks and Mitigations, Part 1: “Global CMC Documentation and CMC Strategies Enabling Global Phase 1 Studies”

May 16, 2024

Heather Finlay, PhD. 
VP Medicinal Chemistry, Exelixis

Why do Drugs Fail and How Can We Do Better?

April 25, 2024

Shihyun You, PhD. 
Professor of Biochemistry, University of Stuttgart, German

Analysis of the specificities of DNA and protein methyltransferases leading to novel insights into epigenetic processes

April 11, 2024

Robert C. Reynolds, PhD
Research Professor of Medicinal Chemistry

Targeted Protein Degradation for Antiviral Drug Discovery

March 28, 2024

Pekka Katajisto, PhD.
Professor, University of Helsinki and Karolinska Institute

Distinguished Speaker Series

March 14, 2024

George Yeoh, BSc (Hons), PhD.
Laboratory Head, Perkins Institute of Medical Research
Liver progenitor/stem cells – a bucket list of experiments.

February 22, 2024

Dr. Theo Heller, MD
Senior Investigator NIH, Bethesda, MD

HDV: D is for Diabolical, or “Are we Winning Yet?”

January 11, 2024

Yongzhen Liu, PhD.
Postdoctoral Research Fellow in the Department of Molecular Biology at Princeton University

Outstanding Young Scientist Series

December 19, 2023

Alex Evilevitch, PhD.
Professor of Cell Biology Lund University, Sweden
Pressurized DNA State Inside Herpes Capsids – A Novel Antiviral Drug Target

November 16, 2023

Dr Renner, PhD.
Postdoctoral Researcher Weiss Lab, University of Pennsylvania, Department of Microbiology

Betacoronaviruses Optimize Replication by Balancing Antagonism of Innate Immune Responses and ER Stress Responses

November 3, 2023

Gianfilippo Coppola, PhD. Departments of Pathology and informatics Yale University School of Medicine
Systems Biology of human Diseases: An Application to Autism Research

October 26, 2023

PST Daphne C. Avgousti, PhD.
Assistant Professor Human Biology Division, Fred Hutch
Viral Manipulation of Host Chromatin

September 7, 2023

Cristina Woo, PhD.
Department of Chemistry and Chemical Biology Harvard University

Sigma-2 and Alzheimer’s Disease: A therapeutic opportunity

Auguts 31, 2023

Patrick Glassman, PhD.
Assistant Professor of Pharmaceutical Sciences at Temple University School of Pharmacy

Drug Delivery Strategies in Acute Critical illness

July 27, 2023

Benjamin E Blass, PhD.
Department of Chemistry and Chemical Biology Harvard University

Sigma-2 and Alzheimer’s Disease: a Therapeutic Opportunity

July 13, 2023

Erle Robertson, PhD.
Harry P. Schenk Endowed Chair Professor Vice-Chair, Department of Otorhinolaryngology -Head and Neck Surgery (with tenure) Professor (tenure), Department of Microbiology Professor (secondary), Department of Radiation Oncolo University of Pennsylvania School of Medicine
Reprogramming of the Epitranscriptome by EBV is Critical for Viral-Associated Tumorigenesis

July 6, 2023

Ertl Hildegund, MD.
Professor, Vaccine & Immunotherapy Center, The Wistar Institute

A therapeutic HBV vaccine containing a novel checkpoint modifier enhances and broadens CD8+ T cell responses which resulted in improved antiviral responses in preclinical studies

June 29, 2023

Jun Wan, PhD
Associate Professor, Medicinal Chemistry, Pharmacology and Chemical Biology Rutgers University

Nick Meanwell, PhD.

Drug design and pharmacology of SARS-CoV-2 main protease inhibitors

June 13, 2023

Patrick Kennedy, MB, BCH, BAO, BMEDSCI, FRCP, MD. Professor of Hepatology, Barts Health NHS Trust

Ju-Tao Guo, MD

The Blurred lines of Chronic Hepatitis B

February 23, 2023

Nick Meanwell, Ph.D., CSci, CChem, FRSC, ACSF.
Distinguished Professor, Baruch S. Blumberg Institute, Former VP, BMS

Inhibitors of HIV-1 Maturation: The Discovery of Fipravirimat

January 19, 2023

John McCauley, PhD.
Senior Director in the Department of Medicinal Chemistry, Merck
PMIX/X Dual Inhibitors: A New Mechanism for the Treatment of Malaria

December 8, 2022

David B. Weiner, PhD.
Executive VP Director, Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia
“Nucleic Acid Vaccines: The Journey”

November 3, 2022

James Shorter, PhD.
Professor of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania
Antagonizing Neurotoxic PhaseTransitions of TDP-43

November 2, 2022

Keith R. Jerome, MD, PhD.
Professor, Vaccine and Infectious Disease Division

New humanized mouse models for HBV gene editing

October 11, 2022

Zhiqiang An, PhD, Professor

Robert A. Welch Distinguished University Chair in Chemistry, University of Texas

Distinguished Speaker Series

June 23, 2022

Kamel Khalili PhD, Laura H. Carnell professor, Department of Neuroscience, Chair and Professor, Department of Microbiology, Immunology and Inflammation, Temple University.

Distinguished Speaker Series

June 9, 2022

Chen Liu, MD, PhD.
Chair and Professor of Pathology, Yale University School of Medicine
Molecular Profiling Liver Disease

April 1, 2022

Dr. Lorne Tyrrell, MD.
2021 Blumberg Prize Recipient
Department of Medical Microbiology and Immunology, University of Alberta

The Long Road to an HBV Cure

March 31, 2022

Peter Leedman, MBBS, PhD, FRACP, FAHMS.
Director of the Harry Perkins Institute of Medical Research, Professor of Medicine at the University of Western Australia
The Rise and Rise of RNA Therapeutics for Liver Disease

March 24, 2022

Drew Weissman, MD, PhD.
Roberts Family Professor in Vaccine Research, University of Pennsylvania Perelman School of Medicine

Distinguished Speaker Series

X